Adverse heart effects of rofecoxib may have been identified years earlier
Tuesday, November 24, 2009 - 07:35
in Health & Medicine
Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004, according to a report in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals...